drugset / Trial / NCT00152464

Prevention of Asthma With Levocetirizine 18 Month Treatment in Infants (12 - 24 Months) Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and/or House Dust Mite (HDM)

NCT00152464

Phase 3 Completed 514 enrolled UCB Pharma
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The Early Prevention of Asthma in Atopic Children (EPAAC™). 24 months study to evaluate the efficacy and safety of levocetirizine (LCTZ) in preventing the onset of asthma in 12 to 24 months old children.

Timeline

Start
2002-03-20
Primary completion
2006-03-15
Completion
2006-03-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Levocetirizine Unknown 0.125 mg/kg Oral

Indications